Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2022		12,106,285
Beginning balance at Dec. 31, 2022	$ 525,960	$ 121	$ 112,042	$ 406,052	$ 7,745
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income	5,231			5,231
Other comprehensive income, net of tax	(2,088)				(2,088)
Employee stock purchase plan (in shares)		26,833
Employee stock purchase plan	1,307		1,307
Stock options exercised (in shares)		25,561
Stock options exercised	737		737
Stock awards vested (in shares)		173,249
Stock awards vested	0	$ 2	(2)
Stock repurchased related to the exercise of stock options and stock awards vested (in shares)		(100,224)
Stock repurchased related to the exercise of stock options and stock awards vested	(5,480)	$ (1)	(5,479)
Stock-based compensation	2,717		2,717
Ending balance (in shares) at Apr. 01, 2023		12,231,704
Ending balance at Apr. 01, 2023	$ 528,384	$ 122	111,322	411,283	5,657
Beginning balance (in shares) at Dec. 31, 2023	14,600,766	14,600,766
Beginning balance at Dec. 31, 2023	$ 636,094	$ 146	206,197	421,980	7,771
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income	6,849			6,849
Other comprehensive income, net of tax	2,243				2,243
Employee stock purchase plan (in shares)		28,773
Employee stock purchase plan	1,190		1,190
Stock options exercised (in shares)		1,625
Stock options exercised	47		47
Stock awards vested (in shares)		152,569
Stock awards vested	0	$ 2	(2)
Stock repurchased related to the exercise of stock options and stock awards vested (in shares)		(77,107)
Stock repurchased related to the exercise of stock options and stock awards vested	(3,765)	$ (1)	(3,764)
Stock-based compensation	$ 2,889		2,889
Ending balance (in shares) at Mar. 30, 2024	14,706,626	14,706,626
Ending balance at Mar. 30, 2024	$ 645,547	$ 147	$ 206,557	$ 428,829	$ 10,014